| About the author: |
I. O. Komarevtseva, S. N. Smirnov, A. Yu. Ihnatova, I. V. Rudenko, K. V. Balabanova, I. A. Vyshnitska, V. N. Komarevtsev |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
Hyperglycemia with or without blood glucose in diabetes range is an emerging finding not uncommonly encountered in patients with COVID-19. This work is to investigate the association between serum alpha-1-antitrypsin, hyperglycemia, and clinical outcomes in COVID-19, and community-acquired pneumonia, gastric cancer and renal cell carcinoma. Alpha-1-antitrypsin levels in serum was determined by the immunoturbidimetric method. We have set the level of alpha-1-antitrypsin in patients with community-acquired pneumonia and COVID-19 with or without hyperglycemia. Levels of alpha-1-antitrypsin in COVID-19 patients with hyperglycemia who survived > those who did not survive. Concentration of alpha-1-antitrypsin levels in COVID-19 men-patients with hyperglycemia who survived was significantly higher than compared with COVID-19 women-patients with hyperglycemia who survived. The obtained data convincingly demonstrate the value of testing the level of alpha-1-antitrypsin in the blood as one of the important indicators of the effectiveness of cancer diagnosis and prognosis. |
| Tags |
alpha-1-antitrypsin,COVID-19,community-acquired pneumonia,gastric cancer,renal cell carcinoma,hyperglycemia |
| Bibliography |
- Berezniakov VI, Кorzh AN, Pavlov SB, Yeroshenko GA, Shevchenko KV, Zvyagolska ІМ. General description of patients with community-acquired pneumonia Who passed an open comparative study. World of Medicine and Biology. 2022; 81(3): 017–021. 10.26724/2079-8334-2022-3-81-21-25
- de Loyola MB, dos Reis TTA, de Oliveira GXLM, da Fonseca Palmeira J, Argañaraz GA, Argañaraz ER. Alpha-1-antitrypsin: A possible host protective factor against Covid-19. Rev Med Virol. 2021;31(2). doi:10.1002/rmv.2157
- El-Akawi. Alpha-1 Antitrypsin Blood Levels as Indicator for the Efficacy of Cancer Treatment. World J Oncol. Published online 2013. doi:10.4021/wjon663e
- Janciauskiene S, Wrenger S, Günzel S, Gründing AR, Golpon H, Welte T. Potential Roles of Acute Phase Proteins in Cancer: Why Do Cancer Cells Produce or Take Up Exogenous Acute Phase Protein Alpha1-Antitrypsin? Front Oncol. 2021;11. doi:10.3389/fonc.2021.622076
- Jiang L, George Hu L. Serpin peptidase inhibitor clade A member 1‑overexpression in gastric cancer promotes tumor progression in vitro and is associated with poor prognosis. Oncol Lett. 2020;20(6). doi:10.3892/OL.2020.12141
- Komarevtseva I, Ihnatova A, Rudenko I, Balabanova K, Komarevtsev V. Liquid biopsy as a tool for predicts of severe COVID-19 and hospitalised community-acquired pneumonia. Pol. Merkur. Lek (Pol Med J), 2022; L (297); 155–159. http://pml.medpress.com.pl/ePUBLI/free/PML297-155.pdf.
- Lin SY, Chang CH, Wu HC, et al. Proteome profiling of urinary exosomes identifies alpha 1-antitrypsin and H2B1K as diagnostic and prognostic biomarkers for urothelial carcinoma. Sci Rep. 2016;6. doi:10.1038/srep34446
- Liu Sping, Zhang Q, Wang W, et al. Hyperglycemia is a strong predictor of poor prognosis in COVID-19. Diabetes Res Clin Pract. 2020;167. doi:10.1016/j.diabres.2020.108338
- Mandili G, Notarpietro A, Khadjavi A, et al. Beta-2-glycoprotein-1 and alpha-1-antitrypsin as urinary markers of renal cancer in von Hippel–Lindau patients. Biomarkers. 2018; 23(2): 123–130. doi:10.1080/1354750X.2016.1269132
- Park SS, Ortega RR, Agudelo CW, et al. Therapeutic potential of alpha-1 antitrypsin in type 1 and type 2 diabetes mellitus. Med. 2021;57(4). doi:10.3390/medicina57040397
- Pertzov B, Shapira G, Abushkara S, Cohen S, Turjeman A, et. al. Lower serum alpha 1 antitrypsin levels in patients with severe COVID-19 compared with patients hospitalized due to non-COVID-19 pneumonia. 2022 Dec;54(12):846–851. doi: 10.1080/23744235.2022.2111464.
- Rojas A, Lindner C, Schneider I, et al. Diabetes mellitus contribution to the remodeling of the tumor microenvironment in gastric cancer. World J Gastrointest Oncol. 2021;13(12):1997–2012. doi:10.4251/wjgo.v13.i12.1997
- Saddam H, Abdus S, Foysal A, et. al. System biology approaches identified novel biomarkers and their signaling pathways involved in renal cell carcinoma with different human diseases. Biosci. Rep. 2022 Nov 30; 42(11): BSR20221108. doi: 10.1042/BSR20221108
- Singh AK, Singh R. Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19. Diabetes Res Clin Pract. 2020;167. doi:10.1016/j.diabres.2020.108382
- Zhang X, Ostrov DA, Tian H. Alpha-1 antitrypsin: A novel biomarker and potential therapeutic approach for metabolic diseases. Clin Chim Acta. 2022;534:71–76. doi:10.1016/j.cca.2022.07.005
|
| Publication of the article |
«World of Medicine and Biology» №1(83), 2023 year, 100-105 pages, index UDK 616.61-006:616.65+576.367 |
| DOI |
10.26724/2079-8334-2023-1-83-100-105 |
